Patients with ABC-DLBCL or genetic alterations in MYC and BCL2 and/or BCL6, called double hit (DHL) or triple hit lymphomas (THL), generally have a poor survival prognosis. This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.